190 related articles for article (PubMed ID: 36192293)
1. The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis.
Kowal S; Ng CD; Schuldt R; Sheinson D; Cookson R
Value Health; 2023 Feb; 26(2):216-225. PubMed ID: 36192293
[TBL] [Abstract][Full Text] [Related]
2. Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.
Meunier A; Longworth L; Gomes M; Ramagopalan S; Garrison LP; Popat S
Pharmacoeconomics; 2023 Aug; 41(8):1011-1025. PubMed ID: 37296369
[TBL] [Abstract][Full Text] [Related]
3. Estimating the US Baseline Distribution of Health Inequalities Across Race, Ethnicity, and Geography for Equity-Informative Cost-Effectiveness Analysis.
Kowal S; Ng CD; Schuldt R; Sheinson D; Jinnett K; Basu A
Value Health; 2023 Oct; 26(10):1485-1493. PubMed ID: 37414278
[TBL] [Abstract][Full Text] [Related]
4. Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities.
Quan AML; Mah C; Krebs E; Zang X; Chen S; Althoff K; Armstrong W; Behrends CN; Dombrowski JC; Enns E; Feaster DJ; Gebo KA; Goedel WC; Golden M; Marshall BDL; Mehta SH; Pandya A; Schackman BR; Strathdee SA; Sullivan P; Tookes H; Nosyk B;
Lancet HIV; 2021 Sep; 8(9):e581-e590. PubMed ID: 34370977
[TBL] [Abstract][Full Text] [Related]
5. Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States.
Goshua G; Calhoun C; Ito S; James LP; Luviano A; Krishnamurti L; Pandya A
Ann Intern Med; 2023 Jun; 176(6):779-787. PubMed ID: 37247420
[TBL] [Abstract][Full Text] [Related]
6. The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis.
Jansen JP; Ragavan MV; Chen C; Douglas MP; Phillips KA
Value Health; 2023 Dec; 26(12):1697-1710. PubMed ID: 37741446
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Baricitinib Compared With Standard of Care: A Modeling Study in Hospitalized Patients With COVID-19 in the United States.
Ohsfeldt R; Kelton K; Klein T; Belger M; Mc Collam PL; Spiro T; Burge R; Ahuja N
Clin Ther; 2021 Nov; 43(11):1877-1893.e4. PubMed ID: 34732289
[TBL] [Abstract][Full Text] [Related]
8. An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective.
Meunier A; Opeifa O; Longworth L; Cox O; Bührer C; Durand-Zaleski I; Kelly SP; Gale RP
Eye (Lond); 2024 Mar; ():. PubMed ID: 38555401
[TBL] [Abstract][Full Text] [Related]
9. Cycle-network expansion plan in Oslo: Modeling cost-effectiveness analysis and health equity impact.
Lamu AN; Norheim OF; Gregersen FA; Barra M
Health Econ; 2021 Dec; 30(12):3220-3235. PubMed ID: 34611965
[TBL] [Abstract][Full Text] [Related]
10. Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact.
Laxy M; Zhang P; Ng BP; Shao H; Ali MK; Albright A; Gregg EW
Appl Health Econ Health Policy; 2020 Oct; 18(5):713-726. PubMed ID: 32607728
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States.
Chatterjee A; Shapouri S; Manzoor BS; Ravelo A; Sail K; Qendri V; van de Wetering G; Davids MS
J Manag Care Spec Pharm; 2021 Nov; 27(11):1532-1544. PubMed ID: 34714110
[No Abstract] [Full Text] [Related]
12. Equity and economic evaluation of system-level health interventions: A case study of Brazil's Family Health Program.
Love-Koh J; Mirelman A; Suhrcke M
Health Policy Plan; 2021 Apr; 36(3):229-238. PubMed ID: 33386400
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study.
Kelton K; Klein T; Murphy D; Belger M; Hille E; McCollam PL; Spiro T; Burge R
Adv Ther; 2022 Jan; 39(1):562-582. PubMed ID: 34807369
[TBL] [Abstract][Full Text] [Related]
14. The effect of medical innovation on the cost-effectiveness of Covid 19-related policies in the United States using a SIR model.
Atherly AJ; van den Broek-Altenburg EM
BMC Health Serv Res; 2023 Apr; 23(1):372. PubMed ID: 37072753
[TBL] [Abstract][Full Text] [Related]
15. Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia.
Dawkins BR; Mirelman AJ; Asaria M; Johansson KA; Cookson RA
Health Policy Plan; 2018 Apr; 33(3):456-463. PubMed ID: 29309581
[TBL] [Abstract][Full Text] [Related]
16. Distributional Cost-Effectiveness Analysis of Health Technologies: Data Requirements and Challenges.
Meunier A; Longworth L; Kowal S; Ramagopalan S; Love-Koh J; Griffin S
Value Health; 2023 Jan; 26(1):60-63. PubMed ID: 35941004
[TBL] [Abstract][Full Text] [Related]
17. Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration.
Killedar A; Lung T; Taylor RW; Hayes A
Appl Health Econ Health Policy; 2023 Jul; 21(4):615-625. PubMed ID: 37221341
[TBL] [Abstract][Full Text] [Related]
18. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.
Claxton K; Martin S; Soares M; Rice N; Spackman E; Hinde S; Devlin N; Smith PC; Sculpher M
Health Technol Assess; 2015 Feb; 19(14):1-503, v-vi. PubMed ID: 25692211
[TBL] [Abstract][Full Text] [Related]
19. Distributional impact of the Malawian Essential Health Package.
Arnold M; Nkhoma D; Griffin S
Health Policy Plan; 2020 Jul; 35(6):646-656. PubMed ID: 32361730
[TBL] [Abstract][Full Text] [Related]
20. A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States.
Sheinson D; Dang J; Shah A; Meng Y; Elsea D; Kowal S
Adv Ther; 2021 Apr; 38(4):1811-1831. PubMed ID: 33650025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
